(RTTNews) – Veeva Systems Inc. (VEEV) has introduced Falcon Safety, a new agentic safety operations product designed to simplify adverse event intake, case processing, and follow-up for biopharma companies.
System Compatibility
Falcon Safety will work seamlessly with Veeva Safety and extend support to any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance. This flexibility allows companies to manage intake and follow-up across multiple platforms without disruption.
Industry Collaboration
Marius Mortensen, vice president of product, Falcon at Veeva, noted that the solution was developed in close collaboration with case processors, pharmacovigilance experts, and safety specialists worldwide. He emphasized Falcon Safety’s role in helping the industry reinvent safety operations.
Availability Timeline
Early adopter access for Falcon Safety is planned for November 2026. The product is part of Veeva AI, the company’s suite of industry-specific AI solutions tailored for life sciences.
Company Profile
Headquartered in Pleasanton, California, Veeva delivers cloud applications, data, and consulting services for life sciences. The company serves more than 1,500 customers, ranging from large pharmaceutical firms to emerging biotechs, and operates as a Public Benefit Corporation, balancing the interests of customers, employees, shareholders, and the broader industry.
VEEV has traded between $148.05 and $310.50 over the past year. The stock closed Tuesday’s trading at $279.23, down 2.26%. During overnight trading, the stock is at $278.78, down 0.16%.
Also Read
- New Zealand’s Critically Endangered Kakapo Birds Achieve Record-Breaking Population Milestone
- Forget the Chip Shortage — Anthropic’s Real Constraint Is Electricity. Here’s the Energy Stock That Wins.
- Europe’s airpower future is evolving. Here’s what to know.
- EU Accuses Russia of State-Sponsored Terror Attempt in Leipzig Drone Attack, Summons Envoy
